Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Quick Facts HQ: Thousand Oaks, California, USA FY2024 Revenue: USD 33.4B FY2024 (+19% YoY)
Abdominal obesity In a 12-month clinical trial published in 2010, which involved 404 HIV-infected patients with excess abdominal fat, the group that received 2mg of tesamorelin per day saw an 18% decrease in visceral fat compared to placebo.9 There are two things to note in order to appreciate the full scope of these findings: Visceral fat (i.e., fat accumulation around the abdominal organs) is famously stubborn and cant be burned selectively through exercise
Pharmaceutical trials exclude pregnant and nursing participants for ethical reasons, leaving lactation-specific data sparse
Meds are 40mg/mL
These benefits become even more pronounced when paired with regular cardiovascular training and strength workouts
Mark Fendrick.
